DNA methylation-based biomarkers in bladder cancerRaju Kandimalla, Ellen C. Zwarthoff, Angela A. van Tilborg|Nature Reviews Urology|2013Cited by 160
Genome-wide Analysis of CpG Island Methylation in Bladder Cancer Identified TBX2, TBX3, GATA2, and ZIC4 as pTa-Specific Prognostic MarkersRaju Kandimalla, Ellen C. Zwarthoff, Angela A.G. van Tilborg et al.|European Urology|2012Cited by 106
<i>FGFR3</i> , <i>TERT</i> and <i>OTX1</i> as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter StudyWillemien Beukers, Ellen C. Zwarthoff, Kirstin A. van der Keur et al.|The Journal of Urology|2017Cited by 92
Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancerDana E. Rathkopf, Andrew J. Armstrong, Jiwen Wu et al.|Annals of Oncology|2024Cited by 66
A 3-Plex Methylation Assay Combined with the <i>FGFR3</i> Mutation Assay Sensitively Detects Recurrent Bladder Cancer in Voided UrineRaju Kandimalla, Ellen C. Zwarthoff, Roy Masius et al.|Clinical Cancer Research|2013Cited by 59